Finepoint Capital LP

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 25Value: $1.3BLatest: 2025Q1

Finepoint Capital LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 25 holdings worth $1.3 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ASND",
  "RVMD",
  "GLPG",
  "SWTX",
  "ARVN",
  "RLAY",
  "PRTA",
  null,
  "QXO",
  "ANNAW",
  "SPY",
  null,
  "RNA",
  "SLDB",
  "MLTX",
  null,
  "CLDI",
  "SRPT",
  "EYPT",
  null,
  "XNCR",
  "LBRDK",
  "LLYVK",
  "CYTK",
  "IWM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 25
Total Value: 1311243830
Accession Number: 0000904454-25-000272
Form Type: 13F-HR
CIK: finepoint-capital-lp
Manager Name: Finepoint-Capital-Lp

Data Enrichment

84% identified

21 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

25 positions • $1.3B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

SPDR S&P 500 ETF TRUST

SPY|78462F103

Shares:755.0K

Value:$422.2M

% of Portfolio:32.2% ($422.2M/$1.3B)

QXO, Inc.

QXO|82846H405

Shares:24.5M

Value:$331.3M

% of Portfolio:25.3% ($331.3M/$1.3B)

464287655

IWM|464287655

Shares:1.5M

Value:$296.3M

% of Portfolio:22.6% ($296.3M/$1.3B)

Liberty Broadband Corp

LBRDK|530307305

Shares:529.2K

Value:$45.0M

% of Portfolio:3.4% ($45.0M/$1.3B)

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:728.6K

Value:$32.2M

% of Portfolio:2.5% ($32.2M/$1.3B)

Liberty Media Corp

LLYVK|531229722

Shares:432.9K

Value:$29.5M

% of Portfolio:2.2% ($29.5M/$1.3B)

Ascendis Pharma A/S

ASND|04351P101

Shares:179.9K

Value:$28.0M

% of Portfolio:2.1% ($28.0M/$1.3B)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:691.3K

Value:$24.4M

% of Portfolio:1.9% ($24.4M/$1.3B)

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:435.8K

Value:$17.0M

% of Portfolio:1.3% ($17.0M/$1.3B)

GALAPAGOS NV

GLPG|36315X101

Shares:656.6K

Value:$16.5M

% of Portfolio:1.3% ($16.5M/$1.3B)

CYTOKINETICS INC

CYTK|23282W605

Shares:309.9K

Value:$12.5M

% of Portfolio:0.9% ($12.5M/$1.3B)

Avidity Biosciences, Inc.

RNA|05370A108

Shares:380.7K

Value:$11.2M

% of Portfolio:0.9% ($11.2M/$1.3B)

Sarepta Therapeutics, Inc.

SRPT|803607100

Shares:157.6K

Value:$10.1M

% of Portfolio:0.8% ($10.1M/$1.3B)

PROTHENA CORP PUBLIC LTD CO

PRTA|G72800108

Shares:640.1K

Value:$7.9M

% of Portfolio:0.6% ($7.9M/$1.3B)

Xencor Inc

XNCR|98401F105

Shares:642.2K

Value:$6.8M

% of Portfolio:0.5% ($6.8M/$1.3B)

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

Shares:1.1M

Value:$5.9M

% of Portfolio:0.4% ($5.9M/$1.3B)

Relay Therapeutics, Inc.

RLAY|75943R102

Shares:2.1M

Value:$5.5M

% of Portfolio:0.4% ($5.5M/$1.3B)

ARVINAS, INC.

ARVN|04335A105

Shares:694.0K

Value:$4.9M

% of Portfolio:0.4% ($4.9M/$1.3B)

Solid Biosciences Inc.

SLDB|83422E204

Shares:961.3K

Value:$3.6M

% of Portfolio:0.3% ($3.6M/$1.3B)

01444V103

Shares:27.7K

Value:$208.7K

% of Portfolio:0.0% ($208.7K/$1.3B)

Instrument	Shares		Other Manager	Value	% of Portfolio
SPDR S&P 500 ETF TRUST(SPYcusip78462F103)	755.0K	QoQ 0.00% (-0) YoY NEW(+755.0K)	All Managers (Combined)	$422.2M	32.2% ($422.2M/$1.3B)	QoQ -4.59% (-$20.3M) YoY NEW(+$422.2M)
QXO, Inc.(QXOcusip82846H405)	24.5M	QoQ -1.86% (-465.7K) YoY NEW(+24.5M)	All Managers (Combined)	$331.3M	25.3% ($331.3M/$1.3B)	QoQ -16.43% (-$65.1M) YoY NEW(+$331.3M)
(IWMcusip464287655)	1.5M	QoQ 0.00% (-0) YoY NEW(+1.5M)	All Managers (Combined)	$296.3M	22.6% ($296.3M/$1.3B)	QoQ -9.71% (-$31.9M) YoY NEW(+$296.3M)
Liberty Broadband Corp(LBRDKcusip530307305)	529.2K	QoQ -73.74% (-1.5M) YoY -71.94% (-1.4M)	All Managers (Combined)	$45.0M	3.4% ($45.0M/$1.3B)	QoQ -70.13% (-$105.7M) YoY -58.30% (-$62.9M)
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	728.6K	QoQ -2.69% (-20.1K) YoY +22.96% (+136.1K)	All Managers (Combined)	$32.2M	2.5% ($32.2M/$1.3B)	QoQ +18.85% (-$5.1M) YoY +10.24% (+$3.0M)
Liberty Media Corp(LLYVKcusip531229722)	432.9K	QoQ -46.73% (-379.9K) YoY NEW(+432.9K)	All Managers (Combined)	$29.5M	2.2% ($29.5M/$1.3B)	QoQ -46.67% (-$25.8M) YoY NEW(+$29.5M)
Ascendis Pharma A/S(ASNDcusip04351P101)	179.9K	QoQ -2.70% (-5.0K) YoY +2.39% (+4.2K)	All Managers (Combined)	$28.0M	2.1% ($28.0M/$1.3B)	QoQ +10.15% (-$2.6M) YoY +5.56% (+$1.5M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	691.3K	QoQ -2.67% (-19.0K) YoY +2.09% (+14.2K)	All Managers (Combined)	$24.4M	1.9% ($24.4M/$1.3B)	QoQ -21.32% (-$6.6M) YoY +12.00% (+$2.6M)
MoonLake Immunotherapeutics(MLTXcusip61559X104)	435.8K	QoQ -2.71% (-12.2K) YoY +20.74% (-74.9K)	All Managers (Combined)	$17.0M	1.3% ($17.0M/$1.3B)	QoQ -29.80% (-$7.2M) YoY -6.08% (-$1.1M)
GALAPAGOS NV(GLPGcusip36315X101)	656.6K	QoQ -2.69% (-18.2K) YoY +30.33% (+152.8K)	All Managers (Combined)	$16.5M	1.3% ($16.5M/$1.3B)	QoQ -11.11% (-$2.1M) YoY +1.67% (+$272.4K)
CYTOKINETICS INC(CYTKcusip23282W605)	309.9K	QoQ -2.66% (-8.5K) YoY +30.20% (-71.9K)	All Managers (Combined)	$12.5M	0.9% ($12.5M/$1.3B)	QoQ -16.84% (-$2.5M) YoY -25.36% (-$4.2M)
Avidity Biosciences, Inc.(RNAcusip05370A108)	380.7K	QoQ -2.70% (-10.6K) YoY NEW(+380.7K)	All Managers (Combined)	$11.2M	0.9% ($11.2M/$1.3B)	QoQ -1.23% (-$140.7K) YoY NEW(+$11.2M)
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	157.6K	QoQ -2.70% (-4.4K) YoY -0.56% (-902)	All Managers (Combined)	$10.1M	0.8% ($10.1M/$1.3B)	QoQ -48.93% (-$9.6M) YoY -50.98% (-$10.5M)
PROTHENA CORP PUBLIC LTD CO(PRTAcusipG72800108)	640.1K	QoQ -2.58% (-17.0K) YoY +59.06% (-237.7K)	All Managers (Combined)	$7.9M	0.6% ($7.9M/$1.3B)	QoQ -12.96% (-$1.2M) YoY -20.53% (-$2.0M)
Xencor Inc(XNCRcusip98401F105)	642.2K	QoQ -2.69% (-17.8K) YoY NEW(+642.2K)	All Managers (Combined)	$6.8M	0.5% ($6.8M/$1.3B)	QoQ -54.94% (-$8.3M) YoY NEW(+$6.8M)
EyePoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	1.1M	QoQ -2.62% (-29.1K) YoY +64.78% (-425.4K)	All Managers (Combined)	$5.9M	0.4% ($5.9M/$1.3B)	QoQ -29.15% (-$2.4M) YoY -56.79% (-$7.7M)
Relay Therapeutics, Inc.(RLAYcusip75943R102)	2.1M	QoQ -2.66% (-58.0K) YoY +42.10% (-627.5K)	All Managers (Combined)	$5.5M	0.4% ($5.5M/$1.3B)	QoQ -38.10% (-$3.4M) YoY -55.14% (-$6.8M)
ARVINAS, INC.(ARVNcusip04335A105)	694.0K	QoQ -2.76% (-19.8K) YoY +28.73% (-154.9K)	All Managers (Combined)	$4.9M	0.4% ($4.9M/$1.3B)	QoQ -64.39% (-$8.8M) YoY -78.10% (-$17.4M)
Solid Biosciences Inc.(SLDBcusip83422E204)	961.3K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.6M	0.3% ($3.6M/$1.3B)	QoQ -7.49% (-$288.4K) YoY -72.22% (-$9.2M)
(cusip01444V103)✕	27.7K	QoQ 0.00% (+0) YoY NEW(+27.7K)	All Managers (Combined)	$208.7K	0.0% ($208.7K/$1.3B)	QoQ +6.05% (+$11.9K) YoY NEW(+$208.7K)